Cargando…
Present developments in reaching an international consensus for a model-based approach to particle beam therapy
Particle beam therapy (PBT), including proton and carbon ion therapy, is an emerging innovative treatment for cancer patients. Due to the high cost of and limited access to treatment, meticulous selection of patients who would benefit most from PBT, when compared with standard X-ray therapy (XRT), i...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5868183/ https://www.ncbi.nlm.nih.gov/pubmed/29529229 http://dx.doi.org/10.1093/jrr/rry008 |
_version_ | 1783309107551272960 |
---|---|
author | Prayongrat, Anussara Umegaki, Kikuo van der Schaaf, Arjen Koong, Albert C Lin, Steven H Whitaker, Thomas McNutt, Todd Matsufuji, Naruhiro Graves, Edward Mizuta, Masahiko Ogawa, Kazuhiko Date, Hiroyuki Moriwaki, Kensuke Ito, Yoichi M Kobashi, Keiji Dekura, Yasuhiro Shimizu, Shinichi Shirato, Hiroki |
author_facet | Prayongrat, Anussara Umegaki, Kikuo van der Schaaf, Arjen Koong, Albert C Lin, Steven H Whitaker, Thomas McNutt, Todd Matsufuji, Naruhiro Graves, Edward Mizuta, Masahiko Ogawa, Kazuhiko Date, Hiroyuki Moriwaki, Kensuke Ito, Yoichi M Kobashi, Keiji Dekura, Yasuhiro Shimizu, Shinichi Shirato, Hiroki |
author_sort | Prayongrat, Anussara |
collection | PubMed |
description | Particle beam therapy (PBT), including proton and carbon ion therapy, is an emerging innovative treatment for cancer patients. Due to the high cost of and limited access to treatment, meticulous selection of patients who would benefit most from PBT, when compared with standard X-ray therapy (XRT), is necessary. Due to the cost and labor involved in randomized controlled trials, the model-based approach (MBA) is used as an alternative means of establishing scientific evidence in medicine, and it can be improved continuously. Good databases and reasonable models are crucial for the reliability of this approach. The tumor control probability and normal tissue complication probability models are good illustrations of the advantages of PBT, but pre-existing NTCP models have been derived from historical patient treatments from the XRT era. This highlights the necessity of prospectively analyzing specific treatment-related toxicities in order to develop PBT-compatible models. An international consensus has been reached at the Global Institution for Collaborative Research and Education (GI-CoRE) joint symposium, concluding that a systematically developed model is required for model accuracy and performance. Six important steps that need to be observed in these considerations include patient selection, treatment planning, beam delivery, dose verification, response assessment, and data analysis. Advanced technologies in radiotherapy and computer science can be integrated to improve the efficacy of a treatment. Model validation and appropriately defined thresholds in a cost-effectiveness centered manner, together with quality assurance in the treatment planning, have to be achieved prior to clinical implementation. |
format | Online Article Text |
id | pubmed-5868183 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-58681832018-03-29 Present developments in reaching an international consensus for a model-based approach to particle beam therapy Prayongrat, Anussara Umegaki, Kikuo van der Schaaf, Arjen Koong, Albert C Lin, Steven H Whitaker, Thomas McNutt, Todd Matsufuji, Naruhiro Graves, Edward Mizuta, Masahiko Ogawa, Kazuhiko Date, Hiroyuki Moriwaki, Kensuke Ito, Yoichi M Kobashi, Keiji Dekura, Yasuhiro Shimizu, Shinichi Shirato, Hiroki J Radiat Res Supplement Paper Particle beam therapy (PBT), including proton and carbon ion therapy, is an emerging innovative treatment for cancer patients. Due to the high cost of and limited access to treatment, meticulous selection of patients who would benefit most from PBT, when compared with standard X-ray therapy (XRT), is necessary. Due to the cost and labor involved in randomized controlled trials, the model-based approach (MBA) is used as an alternative means of establishing scientific evidence in medicine, and it can be improved continuously. Good databases and reasonable models are crucial for the reliability of this approach. The tumor control probability and normal tissue complication probability models are good illustrations of the advantages of PBT, but pre-existing NTCP models have been derived from historical patient treatments from the XRT era. This highlights the necessity of prospectively analyzing specific treatment-related toxicities in order to develop PBT-compatible models. An international consensus has been reached at the Global Institution for Collaborative Research and Education (GI-CoRE) joint symposium, concluding that a systematically developed model is required for model accuracy and performance. Six important steps that need to be observed in these considerations include patient selection, treatment planning, beam delivery, dose verification, response assessment, and data analysis. Advanced technologies in radiotherapy and computer science can be integrated to improve the efficacy of a treatment. Model validation and appropriately defined thresholds in a cost-effectiveness centered manner, together with quality assurance in the treatment planning, have to be achieved prior to clinical implementation. Oxford University Press 2018-03 2018-02-24 /pmc/articles/PMC5868183/ /pubmed/29529229 http://dx.doi.org/10.1093/jrr/rry008 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of The Japan Radiation Research Society and Japanese Society for Radiation Oncology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Supplement Paper Prayongrat, Anussara Umegaki, Kikuo van der Schaaf, Arjen Koong, Albert C Lin, Steven H Whitaker, Thomas McNutt, Todd Matsufuji, Naruhiro Graves, Edward Mizuta, Masahiko Ogawa, Kazuhiko Date, Hiroyuki Moriwaki, Kensuke Ito, Yoichi M Kobashi, Keiji Dekura, Yasuhiro Shimizu, Shinichi Shirato, Hiroki Present developments in reaching an international consensus for a model-based approach to particle beam therapy |
title | Present developments in reaching an international consensus for a model-based approach to particle beam therapy |
title_full | Present developments in reaching an international consensus for a model-based approach to particle beam therapy |
title_fullStr | Present developments in reaching an international consensus for a model-based approach to particle beam therapy |
title_full_unstemmed | Present developments in reaching an international consensus for a model-based approach to particle beam therapy |
title_short | Present developments in reaching an international consensus for a model-based approach to particle beam therapy |
title_sort | present developments in reaching an international consensus for a model-based approach to particle beam therapy |
topic | Supplement Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5868183/ https://www.ncbi.nlm.nih.gov/pubmed/29529229 http://dx.doi.org/10.1093/jrr/rry008 |
work_keys_str_mv | AT prayongratanussara presentdevelopmentsinreachinganinternationalconsensusforamodelbasedapproachtoparticlebeamtherapy AT umegakikikuo presentdevelopmentsinreachinganinternationalconsensusforamodelbasedapproachtoparticlebeamtherapy AT vanderschaafarjen presentdevelopmentsinreachinganinternationalconsensusforamodelbasedapproachtoparticlebeamtherapy AT koongalbertc presentdevelopmentsinreachinganinternationalconsensusforamodelbasedapproachtoparticlebeamtherapy AT linstevenh presentdevelopmentsinreachinganinternationalconsensusforamodelbasedapproachtoparticlebeamtherapy AT whitakerthomas presentdevelopmentsinreachinganinternationalconsensusforamodelbasedapproachtoparticlebeamtherapy AT mcnutttodd presentdevelopmentsinreachinganinternationalconsensusforamodelbasedapproachtoparticlebeamtherapy AT matsufujinaruhiro presentdevelopmentsinreachinganinternationalconsensusforamodelbasedapproachtoparticlebeamtherapy AT gravesedward presentdevelopmentsinreachinganinternationalconsensusforamodelbasedapproachtoparticlebeamtherapy AT mizutamasahiko presentdevelopmentsinreachinganinternationalconsensusforamodelbasedapproachtoparticlebeamtherapy AT ogawakazuhiko presentdevelopmentsinreachinganinternationalconsensusforamodelbasedapproachtoparticlebeamtherapy AT datehiroyuki presentdevelopmentsinreachinganinternationalconsensusforamodelbasedapproachtoparticlebeamtherapy AT moriwakikensuke presentdevelopmentsinreachinganinternationalconsensusforamodelbasedapproachtoparticlebeamtherapy AT itoyoichim presentdevelopmentsinreachinganinternationalconsensusforamodelbasedapproachtoparticlebeamtherapy AT kobashikeiji presentdevelopmentsinreachinganinternationalconsensusforamodelbasedapproachtoparticlebeamtherapy AT dekurayasuhiro presentdevelopmentsinreachinganinternationalconsensusforamodelbasedapproachtoparticlebeamtherapy AT shimizushinichi presentdevelopmentsinreachinganinternationalconsensusforamodelbasedapproachtoparticlebeamtherapy AT shiratohiroki presentdevelopmentsinreachinganinternationalconsensusforamodelbasedapproachtoparticlebeamtherapy |